We have located links that may give you full text access.
CLINICAL TRIAL
COMPARATIVE STUDY
CONTROLLED CLINICAL TRIAL
JOURNAL ARTICLE
Total free radical trapping antioxidant potential in pre-eclampsia.
OBJECTIVE: The aim of the present study was to measure serum urate, tocopherol and ascorbate and to calculate total radical trapping antioxidant potential (TRAP) in pre-eclampsia.
METHODS: Study samples were taken from 25 pre-eclamptic, 25 normotensive pregnant and 25 non-pregnant healthy females for measuring uric acid, vitamin C and E, total sulfhydryl group. Also lipid peroxidation product malonaldehyde (MDA), the superoxide generation (NBT reduction) were estimated and TRAP was calculated. Data were analyzed statistically using Student's t-test.
RESULT: Pre-eclamptic women had significantly increased MDA levels, superoxide generation and uric acid levels as compared to control subjects (P<0.001). Vitamin C and E and total thiols were lower in pre-eclampsia as compared to control subjects (P<0.001). TRAP was significantly higher in pre-eclampsia.
CONCLUSION: TRAP provides a means of assessing the total capacity of the chain-breaking antioxidants to prevent lipid peroxidation in plasma.
METHODS: Study samples were taken from 25 pre-eclamptic, 25 normotensive pregnant and 25 non-pregnant healthy females for measuring uric acid, vitamin C and E, total sulfhydryl group. Also lipid peroxidation product malonaldehyde (MDA), the superoxide generation (NBT reduction) were estimated and TRAP was calculated. Data were analyzed statistically using Student's t-test.
RESULT: Pre-eclamptic women had significantly increased MDA levels, superoxide generation and uric acid levels as compared to control subjects (P<0.001). Vitamin C and E and total thiols were lower in pre-eclampsia as compared to control subjects (P<0.001). TRAP was significantly higher in pre-eclampsia.
CONCLUSION: TRAP provides a means of assessing the total capacity of the chain-breaking antioxidants to prevent lipid peroxidation in plasma.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app